中国科学院机构知识库网格系统: 检索

浏览/检索结果: 共4条，第1-4条

帮助

条数/页：排序方式：
	Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphoma 期刊论文 OAI收割 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 10 作者: Zhang, Xiao-tuan; Hu, Xiao-bei; Wang, Han-lin; Kan, Wei-juan; Xu, Lei \| 收藏 \| 浏览/下载：101/0 \| 提交时间：2020/12/24 DLBCL BTK inhibitor ibrutinib resistance UPR TUDCA 2-DG
	Venetoclax and low-dose cytarabine induced complete remission in a patient with high-risk acute myeloid leukemia: a case report 期刊论文 OAI收割 FRONTIERS OF MEDICINE, 2018, 卷号: 12 - \| 收藏 \| 浏览/下载：18/0 \| 提交时间：2020/10/26 BCL-2 INHIBITOR MIDOSTAURIN CLASSIFICATION DECITABINE MECHANISMS MUTATIONS TARGETS IDH BTK venetoclax cytarabine AML leukemia
	Structure-activity relationship investigation for benzonaphthyridinone derivatives as novel potent Bruton's tyrosine kinase (BTK) irreversible inhibitors 期刊论文 OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 137, 页码: 545-557 作者: Wang, Beilei; Deng, Yuanxin; Chen, Yongfei; Yu, Kailin; Wang, Aoli \| 收藏 \| 浏览/下载：48/0 \| 提交时间：2018/08/16 Btk Kinase Inhibitor Irreversible Inhibitor Structure-activity Relationship B-cell Lymphoma
	Discovery of N-(3-(5-((3-acrylamido-4-(morpholine-4-carbonyl) phenyl)amino)-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methylphenyl)-4-(tert-butyl)benzamide (CHMFL-BTK-01) as a highly selective irreversible Bruton's tyrosine kinase (BTK) inhibitor 期刊论文 OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 131, 页码: 107-125 作者: Liang, Qianmao; Chen, Yongfei; Yu, Kailin; Chen, Cheng; Zhang, Shouxiang \| 收藏 \| 浏览/下载：44/0 \| 提交时间：2018/07/26 Btk Irreversible Inhibitor Kinase Inhibitor Structure-activity Relationship B-cell Lymphoma